McKesson Corporation (NYSE:MCK) is included among the 14 Best American Dividend Stocks to Invest in. Bank of America Sees Upside in McKesson (MCK) Biosimilar Push, Raises Target to $1,040 On March 6, Bank of America raised its price recommendation on McKesson Corporation (NYSE:MCK) to $1,040 from $970. It reiterated a Buy rating on the shares. The firm noted that McKesson recently received a new National Drug Code for a biosimilar version of Neulasta. The approval came a few weeks ago and did not attract ...